SWA
Sutton Wealth Advisors Portfolio holdings
AUM
$203M
1-Year Return
20.54%
This Quarter Return
-13.91%
1 Year Return
+20.54%
3 Year Return
+40.87%
5 Year Return
+61.67%
10 Year Return
–
AUM
$252M
AUM Growth
-$38.7M
(-13%)
Cap. Flow
+$4.86M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
35.59%
Holding
1,747
New
117
Increased
622
Reduced
463
Closed
104
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.06M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$442K |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$321K |
| 4 |
Innovator US Equity Power Buffer ETF April
PAPR
|
+$301K |
| 5 |
iShares Select U.S. REIT ETF
ICF
|
+$245K |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$594K |
| 2 |
Fastly
FSLY
|
+$183K |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$135K |
| 4 |
Chart Industries
GTLS
|
+$134K |
| 5 |
Shoals Technologies Group
SHLS
|
+$116K |
Sector Composition
| 1 | Technology | 15.89% |
| 2 | Healthcare | 12.35% |
| 3 | Financials | 9.44% |
| 4 | Industrials | 6.6% |
| 5 | Consumer Discretionary | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Urban Edge Properties
UE
$2.64B
| $1.38K | ﹤0.01% |
91
-585
| -87% | -$8.9K |
|
1227
Neurocrine Biosciences
NBIX
$14.1B
| $1.37K | ﹤0.01% |
14
-149
| -91% | -$14.5K |
|
1228
Trex
TREX
$6.43B
| $1.36K | ﹤0.01% |
25
+7
| +39% | +$381 |
|
1229
Royalty Pharma
RPRX
$15.8B
| $1.35K | ﹤0.01% |
32
| – | – |
|
1230
Exelixis
EXEL
$10.3B
| $1.33K | ﹤0.01% |
64
+20
| +45% | +$416 |
|
1231
MGM Resorts International
MGM
$9.79B
| $1.33K | ﹤0.01% |
46
-1
| -2% | -$29 |
|
1232
Lamar Advertising Co
LAMR
$12.8B
| $1.32K | ﹤0.01% |
15
+10
| +200% | +$880 |
|
1233
Skyworks Solutions
SWKS
$10.8B
| $1.3K | ﹤0.01% |
14
| – | – |
|
1234
Pentair
PNR
$17.9B
| $1.28K | ﹤0.01% |
28
-20
| -42% | -$916 |
|
1235
iShares Global REIT ETF
REET
$3.87B
| $1.28K | ﹤0.01% |
53
| – | – |
|
1236
Global Partners
GLP
$1.79B
| $1.27K | ﹤0.01% |
+54
| New | +$1.27K |
|
1237
Ingevity
NGVT
$2.1B
| $1.26K | ﹤0.01% |
20
-1
| -5% | -$63 |
|
1238
Regal Rexnord
RRX
$9.41B
| $1.25K | ﹤0.01% |
11
+1
| +10% | +$114 |
|
1239
First Horizon
FHN
$11.5B
| $1.25K | ﹤0.01% |
57
| – | – |
|
1240
Macy's
M
$4.51B
| $1.25K | ﹤0.01% |
68
| – | – |
|
|
SGEN
1241
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.24K | ﹤0.01% |
+7
| New | +$1.24K |
|
1242
Diageo
DEO
$57.9B
| $1.22K | ﹤0.01% |
7
| – | – |
|
1243
CoStar Group
CSGP
$36.3B
| $1.21K | ﹤0.01% |
+20
| New | +$1.21K |
|
1244
EQT Corp
EQT
$31.8B
| $1.2K | ﹤0.01% |
35
| – | – |
|
1245
Darling Ingredients
DAR
$4.95B
| $1.2K | ﹤0.01% |
20
| – | – |
|
1246
PJT Partners
PJT
$4.36B
| $1.2K | ﹤0.01% |
17
| – | – |
|
1247
Owens Corning
OC
$12.7B
| $1.19K | ﹤0.01% |
16
-1
| -6% | -$74 |
|
1248
Halozyme
HALO
$8.84B
| $1.19K | ﹤0.01% |
27
-4
| -13% | -$176 |
|
1249
Aecom
ACM
$16.6B
| $1.17K | ﹤0.01% |
18
+3
| +20% | +$196 |
|
1250
Cullen/Frost Bankers
CFR
$8.12B
| $1.17K | ﹤0.01% |
10
+4
| +67% | +$466 |
|